ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,159
Screening encounters
2,338
Diagnostic referrals
452
Outstanding pathways
192

Screening pathway

  1. Screening2,338Encounters
  2. Positive finding783Documented findings
  3. Referral452Diagnostic referrals
  4. Follow-up500Diagnostic visits
  5. Outcome260Resolved pathways

Stage totals use different units. Pending pathways: 192. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0803 · EXP-0803Synthetic · Site D

Full participant history through 2026-01-16, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-06

Referral-time risk

No matching referral was available at this observation date.

Screened participants

2159 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1161 · Expanded synthetic participant 1161Site E — Resource-Constrained Navigation Programme
EXP-1163 · Expanded synthetic participant 1163Site C — Rural Outreach Programme
EXP-1165 · Expanded synthetic participant 1165Site A — Urban Referral Hub
EXP-1167 · Expanded synthetic participant 1167Site D — Community Engagement Programme
EXP-1168 · Expanded synthetic participant 1168Site B — Peri-Urban Access Programme
EXP-1170 · Expanded synthetic participant 1170Site A — Urban Referral Hub
EXP-1171 · Expanded synthetic participant 1171Site D — Community Engagement Programme
EXP-1173 · Expanded synthetic participant 1173Site A — Urban Referral Hub
EXP-1177 · Expanded synthetic participant 1177Site B — Peri-Urban Access Programme
EXP-1178 · Expanded synthetic participant 1178Site C — Rural Outreach Programme
EXP-1181 · Expanded synthetic participant 1181Site B — Peri-Urban Access Programme
EXP-1184 · Expanded synthetic participant 1184Site E — Resource-Constrained Navigation Programme
EXP-1193 · Expanded synthetic participant 1193Site E — Resource-Constrained Navigation Programme
EXP-1203 · Expanded synthetic participant 1203Site C — Rural Outreach Programme
EXP-1204 · Expanded synthetic participant 1204Site D — Community Engagement Programme
EXP-1205 · Expanded synthetic participant 1205Site B — Peri-Urban Access Programme
EXP-1209 · Expanded synthetic participant 1209Site D — Community Engagement Programme
EXP-1213 · Expanded synthetic participant 1213Site E — Resource-Constrained Navigation Programme
EXP-1216 · Expanded synthetic participant 1216Site E — Resource-Constrained Navigation Programme
EXP-1220 · Expanded synthetic participant 1220Site D — Community Engagement Programme
EXP-1224 · Expanded synthetic participant 1224Site B — Peri-Urban Access Programme
EXP-1225 · Expanded synthetic participant 1225Site B — Peri-Urban Access Programme
EXP-1226 · Expanded synthetic participant 1226Site C — Rural Outreach Programme
EXP-1227 · Expanded synthetic participant 1227Site D — Community Engagement Programme
EXP-1228 · Expanded synthetic participant 1228Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
985
HPV DNA
1007
Cytology
346

Navigation activity

Barrier documented
380
Contact attempt
663
Navigation intervention
158
Diagnostic booking
554
Diagnostic visit
500

Documented barriers

Contact difficulty
118
Transport difficulty
129
Appointment coordination
133

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.